Anika Therapeutics
Price & Volume
Stats
See moreOpen | $20.52 |
Previous Close | $19.45 |
Day Range | $20.14-$20.57 |
52W Range | $9.01-$22.88 |
Market Cap | $260.2M |
Shares Short | 365,717 |
Financials
See moreRevenue (12 Mos) | $120.6M |
Revenue Growth (YoY) | 15.6% |
Gross Profit (12 Mos) | $75M |
Diluted EPS | -$0.23 |
News
See moreYahoo Finance • last month
NVS Gets Positive CHMP Opinion for Cosentyx for Another Indication
Yahoo Finance • 2 months ago
Immunocore Hits Enrollment Target in Kimmtrak Label Expansion Study
Yahoo Finance • 2 months ago
Roche Gets FDA Priority Tag for Enspryng in Rare Autoimmune Disorder
Yahoo Finance • 2 months ago
Novartis' Del-desiran Fails Late-Stage DM1 Study, Shares Fall
About
CEO | Mr. Stephen D. Griffin |
Address | 32 Wiggins Avenue, Bedford, MA, United States, 01730 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 235 |